Skip to main content

Advertisement

Log in

Effect of surfactant on the preparation and characterization of gemcitabine-loaded particles

  • Original Article
  • Published:
Journal of Pharmaceutical Investigation Aims and scope Submit manuscript

Abstract

Gemcitabine is used in the treatment of several solid tumors as one of anticancer nucleoside analogues and is necessary to administer high doses to achieve the desired therapeutic response. However, this treatment may be related to severe side effects. For improvement of the encapsulation efficiency of gemcitabine for gemcitabine-loaded nanoparticle composed of biodegradable polymer and reducing the side effects due to the high concentration of gemcitabine, we formulated gemcitabine-loaded PLGA particles using chitosan and different type of surfactant. The gemcitabine-loaded particles were prepared using a double emulsion solvent evaporation technique. The effects of surfactants to modify the size of gemcitabine-loaded particles were different. The mean diameters of gemcitabine-loaded particles ranged from 400.8 nm to 1712.7 nm. The surface charge of gemcitabine particles was − 5.62 mV to 1.46 mV. The encapsulation efficiency of gemcitabine-loaded particles was found to be 29.56–34.38%. Interestingly, the addition of surfactant could be improved an encapsulation efficiency of gemcitabine.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Fig. 1
Fig. 2
Fig. 3
Fig. 4
Fig. 5
Fig. 6

Similar content being viewed by others

References

  • Abbruzzese JL, Grunewald R, Weeks EA, Gravel D, Adams T, Nowak B, Mineishi S, Tarassoff P, Satterlee W, Raber MN, Plunkett W (1991) A phase I clinical, plasma, and cellular pharmacology study of gemcitabine. J Clin Oncol 9:491–498

    Article  CAS  PubMed  Google Scholar 

  • Bala I, Hariharan S, Kumar MN (2004) PLGA nanoparticles in drug delivery: the state of the art. Crit Rev Ther Drug Carrier Syst 21:387–422

    Article  CAS  PubMed  Google Scholar 

  • Bouffard DY, Lalibert´e J, Momparler RL (1993) Kinetic studies on 2′,2′-difluorodeoxycytidine (gemcitabine) with purified human deoxycytidine kinase and cytidine deaminase. Biochem Pharmacol 45:1857–1861

    Article  CAS  PubMed  Google Scholar 

  • Grunewald R, Kantarjian H, Du M, Faucher K, Tarassoff P, Plunkett W (1992) Gemcitabine in leukemia: a phase 1, clinical, plasma, and cellular pharmacology study. J Clin Oncol 10:406–413

    Article  CAS  PubMed  Google Scholar 

  • Heinemann V, Xu YZ, Chubb S, Sen A, Hertel LW, Grindey GB, Plunkett W (1992) Cellular elimination of 2′,2′-difluorodeoxycytidine 5′-triphosphate: a mechanism of self-potentiation. Cancer Res 52:533–539

    CAS  PubMed  Google Scholar 

  • Hertel LW, Border GB, Kroin JS, Rinzel SM, Poore GA, Todd GC, Grindey GB (1990) Evaluation of the antitumor activity of gemcitabine(2′,2′-difluoro-2′-deoxycytidine). Cancer Res 50:4417–4422

    CAS  PubMed  Google Scholar 

  • Horton ND (2004) Toxicity of single-dose oral gemcitabine in mice. Cancer Res 4:27–31

    Google Scholar 

  • Jaidev LR, Krishnan UM, Sethuraman S (2015) Gemcitabine loaded biodegradable PLGA nanospheres for in vitro pancreatic cancer therapy. Mater Sci Eng C 47:40–47

    Article  CAS  Google Scholar 

  • Jang JY, Kwon BS, Lee HE, Kim DH, Kang HK, Kang JS, Lee SK, Choi GJ (2007) Preparation of biodegradable PLGA nanospheres employing a fast solvent evaporation method. J Ind Eng Chem 13:1043–1046

    CAS  Google Scholar 

  • Khoee S, Yaghoobian M (2009) An investigation into the role of surfactants in controlling particle size of polymeric nanocapsules containing penicillin-G in double emulsion. Eur J Med Chem 44:2392–2399

    Article  CAS  PubMed  Google Scholar 

  • Matsuda A, Sasaki T (2004) Antitumor activity of sugar-modified cytosine nucleosides. Cancer Sci 95:105–111

    Article  CAS  PubMed  Google Scholar 

  • Myhren F, Borretzen B, Dalen A, Sandvold ML (2002) Gemcitabine derivatives. US Patent US2,002,042,391

  • Nafee N, Taetz S, Schneider M, Schaefer UF, Lehr CM (2007) Chitosan-coated PLGA nanoparticles for DNA/RNA delivery: effect of the formulation parameters on complexation and transfection of antisense oligonucleotides. Nanomedicine: nanotechnology biology medicine 3:173–183

    Article  CAS  Google Scholar 

  • Plunkett W, Huang P, Gandhi V (1995) Preclinical characteristics of gemcitabine. Anticancer drugs 6:7–13

    Article  CAS  PubMed  Google Scholar 

  • Reddy LH, Couvreur P (2008) Novel approaches to deliver gemcitabine to cancers. Curr Pharm Design 14:1124–1137

    Article  CAS  Google Scholar 

  • Shipley LA, Brown TJ, Cornpropst JD, Hamiton M, Daniels WD, Culp HW (1992) Metabolism and disposition of gemcitabine, and oncolytic deoxycytidine analog, in mice, rats, and dogs. Drug Metab Dispos 20:849–855

    CAS  PubMed  Google Scholar 

  • Storniolo AM, Allerheiligen SRB, Pearce HL (1997) Preclinical, pharmacologic, and phase I studies of gemcitabine. Semin Oncol 24:S7-2–S7-7

  • Tewes F, Munnier E, Antoon B, Ngaboni Okassa L, Cohen-Jonathan S, Marchais H, Douziech-Eyrolles L, Soucé M, Dubois P, Chourpa I (2007) Comparative study of doxorubicin-loaded poly(lactide-co-glycolide) nanoparticles prepared by single and double emulsion methods. Eur J Pharm Biopharm 66:488–492

    Article  CAS  PubMed  Google Scholar 

  • van der Lubben IM, Verhoef JC, van Aelst AC, Borchard G, Junginger HE (2001) Chitosan microparticles for oral vaccination: preparation, characterization and preliminary in vivo uptake studies in murine Peyer’s patches. Biomaterials 22:687–694

    Article  PubMed  Google Scholar 

  • Zhang X, Sun M, Zheng A, Cao D, Bi Y, Sun J (2012) Preparation and characterization of insulin-loaded bioadhesive PLGA nanoparticles for oral administration. Eur J Pharm Biopharm 45:632–638

    CAS  Google Scholar 

Download references

Acknowledgements

This article does not contain any studies with human and animal subjects performed by any of the authors. All authors (J.H. Lim, Y.G. Na, H.K. Lee, K.H. Bang, S.J. Kim, H.J. Lee, M. Wang, Y.C. Pyo, H.W. Huh, C.W. Cho) declare that they have no conflict of interest. This work was supported by the research fund of Chungnam National University.

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Cheong-Weon Cho.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Lim, JH., Na, YG., Lee, HK. et al. Effect of surfactant on the preparation and characterization of gemcitabine-loaded particles. J. Pharm. Investig. 49, 271–278 (2019). https://doi.org/10.1007/s40005-018-0402-8

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s40005-018-0402-8

Keywords

Navigation